Alexion Pharmaceuticals - Company & Market Research Reports

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.


Monoclonal Antibodies Market: By Application [Oncology, Autoimmune and inflammatory diseases, Respiratory diseases and Ophthalmology] & By Geography - Forecast 2016-2021 - Product Thumbnail Image

Monoclonal Antibodies Market: By Application [Oncology, Autoimmune and inflammatory diseases, Respiratory diseases and Ophthalmology] & By Geography - Forecast 2016-2021

  • Report
  • 135 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape - Product Thumbnail Image

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape

  • Report
  • 161 Pages
From
Global Monoclonal Antibodies Market 2016-2020 - Product Thumbnail Image

Global Monoclonal Antibodies Market 2016-2020

  • Report
  • 160 Pages
From
The Development of Therapeutic Monoclonal Antibody Products - Product Thumbnail Image

The Development of Therapeutic Monoclonal Antibody Products

  • Report
Global Biopharma Outlook 2012 - Rising Stars and Mature Biotech - Product Thumbnail Image

Global Biopharma Outlook 2012 - Rising Stars and Mature Biotech

  • Report
  • 130 Pages
From
Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 89 Pages
From
Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market) - Product Thumbnail Image

Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market)

  • Report
  • 98 Pages
From
Biologics Outsourcing Global Market - Forecast to 2025 - Product Thumbnail Image

Biologics Outsourcing Global Market - Forecast to 2025

  • Report
  • 527 Pages
From
Global Markets and Manufacturing Technologies for Protein Drugs - Product Thumbnail Image

Global Markets and Manufacturing Technologies for Protein Drugs

  • Report
  • 176 Pages
From
Fc Protein and Glycoengineered Antibodies Market (2nd Edition), 2016 - 2026 - Product Thumbnail Image

Fc Protein and Glycoengineered Antibodies Market (2nd Edition), 2016 - 2026

  • Report
  • 327 Pages
From
Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease - Product Thumbnail Image

Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

  • Report
  • 160 Pages
From
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015 - Product Thumbnail Image

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015

  • Report
  • 57 Pages
From
Biotechnology and Pharmaceuticals Report - Product Thumbnail Image

Biotechnology and Pharmaceuticals Report

  • Report
  • 20 Pages
From
Antibody Drugs: Technologies and Global Markets - Product Thumbnail Image

Antibody Drugs: Technologies and Global Markets

  • Report
  • 115 Pages
From
Inborn Gene or Chromosome Alterations Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 - Product Thumbnail Image

Inborn Gene or Chromosome Alterations Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • Report
  • 429 Pages
From
Orphan Drug Pricing and Reimbursement - Product Thumbnail Image

Orphan Drug Pricing and Reimbursement

  • Report
  • 43 Pages
From
Kidney Transplant Rejection - Pipeline Review, H2 2017 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Review, H2 2017

  • Report
  • 171 Pages
From
Kidney Transplantation - Pipeline Review, H1 2016 - Product Thumbnail Image

Kidney Transplantation - Pipeline Review, H1 2016

  • Report
  • 176 Pages
From
Kidney Transplantation - Pipeline Review, H1 2015 - Product Thumbnail Image

Kidney Transplantation - Pipeline Review, H1 2015

  • Report
  • 148 Pages
From
Loading Indicator
adroll